共 35 条
[1]
De Smedt T(2007)Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug CNS Drug Rev 13 57-78
[2]
Raedt R(2012)Guidelines for the evaluation and management of status epilepticus Neurocrit Care 17 3-23
[3]
Vonck K(2009)Safety and efficacy of levetiracetam for critically ill patients with seizures Neurocrit Care 11 34-37
[4]
Boon P(2004)Clinical pharmacokinetics of levetiracetam Clin Pharmacokinet 43 707-724
[5]
Brophy GM(2007)Drug dosing in continuous renal replacement therapy: general rules Curr Opin Crit Care 13 645-651
[6]
Bell R(2015)Levetiracetam pharmacokinetics in a patient receiving continuous venovenous hemofiltration and venoarterial extracorporeal membrane oxygenation Pharmacotherapy 35 e127-e130
[7]
Claassen J(2008)Antiepileptic drugs–best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies Epilepsia 49 1239-1276
[8]
Nau KM(2004)Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society Neurology 62 1252-1260
[9]
Divertie GD(2001)Use of levetiracetam in special populations Epilepsia 42 40-43
[10]
Valentino AK(2012)Continuous renal-replacement therapy for acute kidney injury N Engl J Med 367 2505-2514